Amnestic Mild Cognitive Impairment
📧 Sign up to get email alerts when something new happens for Amnestic Mild Cognitive Impairment.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-12Clinical Trial Results: Cognitive Outcomes of Brain Stimulation As a Later-in-Life Treatment [NA]
This clinical trial reports results on cognitive outcomes of a brain stimulation approach as a treatment in later life for individuals with …
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: Does Psilocybin Change Synaptic Density in Amnestic Mild Cognitive Impairment [Phase 2]
A Phase 2 clinical trial is evaluating whether psilocybin affects synaptic density in individuals with amnestic mild cognitive impairment; t…
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: Auditory Stimulation During Sleep to Enhance Long-Term Memory in Amnestic MCI [NA]
A completed clinical trial evaluated auditory stimulation during sleep to enhance long-term memory in individuals with mild cognitive impair…
-
CLINICAL_TRIALS trial_result · 2025-09-11Clinical Trial Update: The Effect of Electroacupuncture Treatment on Cognitive Function in Adults With Amnestic Mild Cognitive Impairment [NA]
The trial update reports on a completed study evaluating the effect of electroacupuncture on cognitive function in adults with amnestic mild…
-
CLINICAL_TRIALS trial_result · 2025-08-24Clinical Trial Update: Cognitive Outcomes of Brain Stimulation As a Later-in-Life Treatment [NA]
This document provides an update on a completed clinical trial evaluating brain stimulation as a treatment for cognitive decline in older ad…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-07-29Clinical Trial Update: Interleaved TMS-fMRI for Hippocampal Stimulation: Modeling Dose-Response Relationship in Amnestic Mild Cognitive Impairment [Phase 2]
Phase 2 study assessing the dose–response of hippocampal stimulation using interleaved TMS-fMRI in amnestic mild cognitive impairment; the t…
-
CLINICAL_TRIALS trial_result · 2025-07-24Clinical Trial Update: Neuro RX Gamma for Amnestic Mild Cognitive Impairment (aMCI) [EARLY_Phase 1]
The EARLY_PHASE1 trial of Neuro RX Gamma for amnestic mild cognitive impairment has completed.
-
CLINICAL_TRIALS trial_result · 2025-01-14Clinical Trial Update: mSIM: Mobile Simultaneous Aerobic Exercise and Memory Training Intervention for Amnestic Mild Cognitive Impairment [NA]
A terminated clinical trial evaluating a mobile aerobic exercise and memory training intervention for amnestic mild cognitive impairment has…
-
CLINICAL_TRIALS trial_result · 2020-05-18Clinical Trial Update: The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF) [Phase 2, Phase 3]
The SNIFF study evaluating intranasal insulin for amnestic mild cognitive impairment and Alzheimer's disease has completed its Phase 2/3 por…
-
CLINICAL_TRIALS trial_result · 2019-05-17Clinical Trial Update: Efficacy and Safety Trial of Verubecestat (MK-8931) in Participants With Prodromal Alzheimer's Disease (MK-8931-019) [Phase 3]
Phase 3 trial of verubecestat (MK-8931) in prodromal Alzheimer's disease and amnestic MCI was terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2019-02-19Clinical Trial Update: CTA-MCI: Cognitive Control Training in Patients With Amnestic Mild Cognitive Impairment(CTA-MCI) [NA]
CTA-MCI is a clinical trial evaluating cognitive control training in individuals with amnestic mild cognitive impairment. The sponsor is the…
-
CLINICAL_TRIALS trial_result · 2018-10-01Clinical Trial Update: An Open-Label Study Investigating MK-8931 in Participants With Mild and Moderate Hepatic Insufficiency (MK-8931-016) [Phase 1]
Phase 1 open-label study of MK-8931 in participants with hepatic impairment; results completed with conditions including amnestic mild cogni…
-
CLINICAL_TRIALS trial_result · 2018-07-23Clinical Trial Update: [18F]MK-6240 Positron Emission Tomography (PET) Tracer First-in-Human Validation Study (MK-6240-001) [Phase 1]
First-in-human validation study of the PET tracer [18F]MK-6240 (MK-6240-001) completed in Phase 1 for Alzheimer's disease and amnestic mild …
-
CLINICAL_TRIALS trial_result · 2018-04-05Clinical Trial Update: A Combined Training Program for Veterans With Amnestic Mild Cognitive Impairment [NA]
Clinical trial update describing completion of a combined training program for veterans with amnestic mild cognitive impairment.
-
CLINICAL_TRIALS trial_result · 2015-04-22Clinical Trial Update: Study of the Pharmacokinetics and Pharmacodynamics of POSIPHEN® in Subjects With Amnestic Mild Cognitive Impairment [Phase 1]
A Phase 1 pharmacokinetics and pharmacodynamics study of POSIPHEN in subjects with amnestic mild cognitive impairment and Alzheimer's diseas…
-
CLINICAL_TRIALS trial_result · 2014-11-13Clinical Trial Update: Outcome Predictors of a Cognitive Intervention in aMCI
A completed clinical trial evaluating predictors of outcomes from a cognitive intervention in individuals with amnestic mild cognitive impai…